ProfileGDS5678 / 1445328_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 26% 25% 25% 24% 25% 26% 25% 25% 25% 25% 25% 25% 25% 25% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.6261726
GSM967853U87-EV human glioblastoma xenograft - Control 22.5832225
GSM967854U87-EV human glioblastoma xenograft - Control 32.5846225
GSM967855U87-EV human glioblastoma xenograft - Control 42.5089324
GSM967856U87-EV human glioblastoma xenograft - Control 52.5314825
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6612426
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.6079925
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5583525
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5529325
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.56925
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.567125
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5472325
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5757125
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.572225